Sign In
Buy 1875
HK$1.86
-0.0300 (-1.59%)
At Close: Nov 18, 2025
TOT Biopharm International Earnings Calls
Jun 30, 2025
| Release date | Aug 12, 2025 |
| EPS estimate | - |
| EPS actual | HK$0.0061 |
| Revenue estimate | - |
| Revenue actual | 535.168M |
Dec 31, 2024
| Release date | Mar 13, 2025 |
| EPS estimate | - |
| EPS actual | HK$0.0047 |
| Revenue estimate | - |
| Revenue actual | 614.585M |
Jun 30, 2024
| Release date | Nov 12, 2024 |
| EPS estimate | - |
| EPS actual | HK$0.0467 |
| Revenue estimate | - |
| Revenue actual | 559.076M |
Dec 31, 2023
| Release date | Mar 15, 2024 |
| EPS estimate | - |
| EPS actual | -HK$0.0345 |
| Revenue estimate | 806.97M |
| Revenue actual | 500.901M |
| Revenue Surprise | -37.93% |
Last 4 Quarters for TOT Biopharm International
Below you can see how 1875.HK performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Dec 31, 2023
| Release date | Mar 15, 2024 |
| Price on release | HK$1.73 |
| EPS estimate | - |
| EPS actual | -HK$0.0345 |
| Date | Price |
|---|---|
| Mar 11, 2024 | HK$1.70 |
| Mar 12, 2024 | HK$1.64 |
| Mar 13, 2024 | HK$1.65 |
| Mar 14, 2024 | HK$1.60 |
| Mar 15, 2024 | HK$1.73 |
| Mar 18, 2024 | HK$1.57 |
| Mar 19, 2024 | HK$1.54 |
| Mar 20, 2024 | HK$1.55 |
| Mar 21, 2024 | HK$1.55 |
| 4 days before | 1.76% |
| 4 days after | -10.40% |
| On release day | -9.25% |
| Change in period | -8.82% |
Jun 30, 2024
| Release date | Nov 12, 2024 |
| Price on release | HK$1.86 |
| EPS estimate | - |
| EPS actual | HK$0.0467 |
| Date | Price |
|---|---|
| Nov 06, 2024 | HK$1.65 |
| Nov 07, 2024 | HK$1.70 |
| Nov 08, 2024 | HK$1.69 |
| Nov 11, 2024 | HK$1.70 |
| Nov 12, 2024 | HK$1.86 |
| Nov 13, 2024 | HK$1.75 |
| Nov 14, 2024 | HK$1.74 |
| Nov 15, 2024 | HK$1.74 |
| Nov 18, 2024 | HK$1.74 |
| 4 days before | 12.73% |
| 4 days after | -6.45% |
| On release day | -5.91% |
| Change in period | 5.45% |
Dec 31, 2024
| Release date | Mar 13, 2025 |
| Price on release | HK$1.95 |
| EPS estimate | - |
| EPS actual | HK$0.0047 |
| Date | Price |
|---|---|
| Mar 07, 2025 | HK$2.03 |
| Mar 10, 2025 | HK$2.06 |
| Mar 11, 2025 | HK$2.10 |
| Mar 12, 2025 | HK$2.08 |
| Mar 13, 2025 | HK$1.95 |
| Mar 14, 2025 | HK$2.09 |
| Mar 17, 2025 | HK$2.06 |
| Mar 18, 2025 | HK$2.08 |
| Mar 19, 2025 | HK$2.03 |
| 4 days before | -3.94% |
| 4 days after | 4.10% |
| On release day | 7.18% |
| Change in period | 0% |
Jun 30, 2025
| Release date | Aug 12, 2025 |
| Price on release | HK$2.49 |
| EPS estimate | - |
| EPS actual | HK$0.0061 |
| Date | Price |
|---|---|
| Aug 06, 2025 | HK$2.50 |
| Aug 07, 2025 | HK$2.41 |
| Aug 08, 2025 | HK$2.37 |
| Aug 11, 2025 | HK$2.57 |
| Aug 12, 2025 | HK$2.49 |
| Aug 13, 2025 | HK$2.39 |
| Aug 14, 2025 | HK$2.36 |
| Aug 15, 2025 | HK$2.36 |
| Aug 18, 2025 | HK$2.48 |
| 4 days before | -0.400% |
| 4 days after | -0.402% |
| On release day | -4.02% |
| Change in period | -0.80% |
TOT Biopharm International Earnings History
Earnings Calendar
FAQ
When is the earnings report for 1875.HK?
TOT Biopharm International Co Ltd (1875.HK) has scheduled its earnings report for Mar 09, 2026 before the markets open.
What is the 1875.HK price-to-earnings (P/E) ratio?
1875.HK P/E ratio as of Nov 18, 2025 (TTM) is 169.64.
What is the 1875.HK EPS forecast?
The forecasted EPS (Earnings Per Share) for TOT Biopharm International Co Ltd (1875.HK) for the first fiscal quarter 2025 is HK$.
What are TOT Biopharm International Co Ltd's retained earnings?
On its balance sheet, TOT Biopharm International Co Ltd reported retained earnings of HK$535.17 million for the latest quarter ending Jun 30, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
